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Paratyphoid Fever in India: An Emerging
Problem
To the Editor: Enteric fever is a major public
health problem in India, accounting for more
than 300,000 cases per year, Salmonella typhi is
the most common etiologic agent (1), but
Salmonella paratyphi A, the other causative
agent, causes more asymptomatic infections
than  S. typhi. According to earlier reports from
India,  S. paratyphi A was implicated as a
causative agent in 3%-17% of enteric fever cases
(2). However, a large community-based study in
an urban slum of Delhi during October 1995 to
October 1996 found that S. paratyphi A caused
approximately 20%-25% of the cases of enteric
fever in this region (3). An outbreak of enteric
fever due to a single S. paratyphi A strain in an
urban residential area was reported in 1996 from
New Delhi, where contaminated water was
implicated as the probable source (4,5). This
outbreak prompted a retrospective analysis of
the laboratory records of the All India Institute of
Medical Sciences, New Delhi, over a 5-year
period (1994-1998) to study the change, if any, in
the etiology of enteric fever in North India.
We evaluated all blood culture records from
the institutes clinical bacteriology laboratory for
April to October (the months with the highest
number of enteric fever cases) each year. Records
were from patients residing in New Delhi and the
surrounding areas of North India. The blood was
collected by a phlebotomist in the outpatient
department or by a resident doctor in hospital
wards. Blood cultures were carried out by
standard laboratory technique (6). Five ml of
blood was added to 50 ml of brain heart infusion
broth (Hi-Media Laboratory, India) under
aseptic conditions. Bacterial identification was
accomplished by standard microbiologic protocol
(6). Susceptibility to antibiotics (amoxycillin,
chloramphenicol, cotrimoxazole, gentamicin,
ciprofloxacin, and ceftriaxone) was tested by the
comparative disk diffusion method (Stokes
method) (7). Chi-square for trend was calculated,
and the p value was determined.
The total number of blood cultures per-
formed for enteric fever cases (10,109 in 1994,
12,092 in 1995, 17,652 in 1996, 15,997 in 1997,
and 17,012 in 1998) did not change significantly
over this period. The isolation of S. typhi changed
little (Chi-square = 2.367; p = 0.123; statistically
not significant). However, the proportion of
S. paratyphi A isolates rose from 6.5% in 1994 to
44.9% in 1998 (Chi-square = 22.20; p <0.001;
statistically significant). The proportion of
S. paratyphi A isolations in enteric fever cases
from 1994 to 1998 was 6.5%, 21.2%, 50.5%, 30.7%,
and 44.9%, respectively. Even excluding the
strains from the 1996 outbreak (4), we found that
the proportion of S. paratyphi A in enteric fever
cases increased compared with S. typhi (Chi-
square = 30.528; p <0.001). With our catchment
area,  case definition of enteric fever, and
laboratory methods remaining the same during
this period, it appears that the etiology of enteric
fever in North India is changing significantly.
The age-wise distribution of S. typhi and
S. paratyphi A showed that S. typhi was a
significant isolate from children < 5 years of age,
while this distribution was not observed for
S. parathyphi A, which involved those > 5 years484 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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of age. Sex was not significantly associated
(mean male to female sex ratio was 32.4:18
for  S. typhi and 15.8:10.6 for S. paratyphi A).
S. typhi has become increasingly sensitive to
amoxycillin, chloramphenicol, and gentamicin,
increasing from 75.1% in 1994 to 96.6% in 1998
for amoxycillin, from 71.9% in 1994 to 91.6% in
1998 for chloramphenicol, and from 96.4% to
100% for gentamicin. S. paratyphi A strains have
remained uniformly sensitive (100%) to all
antibiotics (amoxycillin, chloramphenicol, and
gentamicin, as well as ciprofloxacin and
ceftriaxone) used in the treatment of enteric
fever. In light of reports of multidrug resistance
in S. typhi, especially to quinolones, continued
surveillance and monitoring of antimicrobial
sensitivity of S. paratyphi A strains are needed.
The increase in proportion of S. paratyphi A
cases, which may be due to a high degree of
clinical suspicion (with mild fever cases
investigated for enteric fever), changing host
susceptibility, or even change in the virulence of
the organism, should be further investigated.
Seema Sood, Arti Kapil, Nihar Dash,
Bimal K. Das, Vikas Goel, and Pradeep Seth
All India Institute of Medical Sciences,
New Delhi, India
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Hepatitis C Virus RNA Viremia in
Central Africa
To the Editor: Epidemiologic serosurveys have
demonstrated high prevalence (6%-15%) of
hepatitis C virus (HCV) infection in adults in
sub-Saharan Africa (1-4). Although possible
false-positive HCV serologic test results have
been reported in Africa, HCV prevalence rates
suggest a high rate of chronic infection among
persons with anti-HCV antibodies (5,6). We have
focused on HCV RNA infectivity of blood from
donors attending the National Blood Center in
Bangui, Central African Republic.
We prospectively tested all blood donors
between February and April 1998 for serum anti-
HCV antibodies by both an HCV third-
generation enzyme-linked immunosorbent assay
(ELISA) (Abbott HCV EIA 3.0 test, Abbott,
Chicago, IL, USA), which was chosen as a
reference test for immunoglobulin (Ig) G
antibodies to HCV, and by a simple membrane
immunoassay system (Ortho HCV Ab Quik Pack,
Ortho Diagnostic Systems Inc., Tokyo, Japan)
(7).   Anti-HCV-positive serum samples were
further subjected to qualitative detection of HCV
RNA by reverse transcription-polymerase chain
reaction (AMPLICOR-HCV, Roche Diagnostic
Systems, Inc., Branchburg, NJ, USA) (8). Of 163
serum samples (mean age ± standard deviation,
30±8 years), 155 were from male blood donors, 83
(51%) from first-time donors, and 125 (77%) from
donors in the recipients family. Fifteen (9.2%;
95% confidence interval [CI] 5%-15%) samples
contained IgG to HCV by ELISA. Of the ELISA-
positive samples, 14 were positive by the Quik
Pack assay (sensitivity, 93.0%); of the 148
remaining ELISA-negative samples, 147 were
negative by the Quik Pack assay (specificity,
99.3%). The agreement between the results of
the two methods was 98.7%. Of the 163 samples,
10 (6.1%; CI 95%: 3%-11%) were positive for HCV
antibodies (by ELISA and rapid test) and for
HCV RNA.
We confirmed a high prevalence of HCV-
seropositivity among blood donors in Bangui and
the subsequent high rate of HCV RNA viremic
blood donations. To offset the major risk for
transfusion-acquired  HCV in Central Africa we
recommend screening donated blood for anti-
HCV. When laboratory facilities to perform
ELISA are not available, the Quik Pack system,